XORTX Therapeutics (XRTX) Operating Expenses (2020 - 2026)

XORTX Therapeutics' (XRTX) quarterly Operating Expenses came in at $139937.0 in Q1 2026, down 0.56% on a QoQ basis from $140728.0 in Q3 2025.

XORTX Therapeutics (XRTX) Operating Expenses (2020 - 2026) Analysis & Trends

XORTX Therapeutics (XRTX) has 7 years of Operating Expenses data on file, last reported at $139937.0 in Q1 2026.

Quarterly Operating Expenses changed N/A year-over-year to $139937.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $280665.0 (up 90.5% YoY) and the FY2025 annual result came in at $670131.4, up 41.99% from the prior year.
Operating Expenses slipped to $139937.0 in Q1 2026, from $140728.0 in the prior quarter.
In the past five years, Operating Expenses ranged from a high of $2.0 million in Q1 2022 to a low of -$1.8 million in Q4 2023.
A 5-year average of $604999.9 and a median of $599718.3 in 2023 frame the typical range for Operating Expenses.
Annual changes were most pronounced in 2022 — Operating Expenses soared 10431.25% — and 2023, when it slumped 220.76%.
Tracing XRTX's Operating Expenses over 5 years: stood at $1.5 million in 2022, then tumbled by 220.76% to -$1.8 million in 2023, then surged by 108.19% to $147329.0 in 2024, then declined by 4.48% to $140728.0 in 2025, then slipped by 0.56% to $139937.0 in 2026.
The last three Operating Expenses figures came in at $139937.0 (Q1 2026), $140728.0 (Q3 2025), and $147329.0 (Q3 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Opex (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	2.09 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	3.00 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	2.89 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	960.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	1.21 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	1.06 Bn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	427.03 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	541.02 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-784.57 Mn
10	XORTX Therapeutics	2.78 Mn	2.78 Mn	-	139,937.00

Download Data